Wildcat Capital Management, LLC Quant / Systematic

Location: New York, NY

CIK: 0001582384 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Dec 2, 2016

Total Value: $265M (100.0% shares, 0.0% debt)

Holdings (20)

KITE PHARMA INC 44.4%
Value $118M Shares 2,358,084 Est. Cost $57.67 Unrealized
CSGP COSTAR GROUP INC 20.8%
Value $55.07M Shares 251,837 Est. Cost $16.16 Unrealized +22.4%
NANTKWEST INC 10.5%
Value $27.96M Shares 4,495,495 Est. Cost $11.46 Unrealized
SRNE SORRENTO THERAPEUTICS INC 5.9%
Value $15.68M Shares 2,799,790 Est. Cost $12.08 Unrealized -47.1%
HILTON WORLDWIDE HLDGS INC 4.3%
Value $11.38M Shares 505,000 Est. Cost $22.73 Unrealized
MDXG MIMEDX GROUP INC 3.2%
Value $8.621M Shares 1,080,365 Est. Cost $8.80 Unrealized -11.6%
ISHARES TR 2.6%
Value $6.88M Shares 61,073 Est. Cost Unrealized
LPLA LPL FINL HLDGS INC 1.7%
Value $4.612M Shares 206,647 Est. Cost $43.12 Unrealized -41.8%
COMMUNICATIONS SALES & LEAS IN 1.6%
Value $4.364M Shares 151,000 Est. Cost $18.69 Unrealized
NANTHEALTH INC 1.1%
Value $3.008M Shares 240,648 Est. Cost $12.50 Unrealized
ISHARES TR 0.9%
Value $2.279M Shares 27,164 Est. Cost Unrealized
ISHARES TR 0.6%
Value $1.552M Shares 13,580 Est. Cost Unrealized
EDIT EDITAS MEDICINE INC 0.5%
Value $1.459M Shares 59,800 Est. Cost $26.29 Unrealized +28.3%
ISHARES TR 0.5%
Value $1.243M Shares 4,830 Est. Cost Unrealized
SPDR S&P 500 ETF TR 0.3%
Value $864K Shares 4,126 Est. Cost Unrealized
DXJ WISDOMTREE TR 0.3%
Value $776K Shares 20,000 Est. Cost $38.80 Unrealized
TLT ISHARES TR 0.3%
Value $669K Shares 4,832 Est. Cost $138.45 Unrealized
NTLA INTELLIA THERAPEUTICS INC 0.2%
Value $534K Shares 25,000 Est. Cost $26.61 Unrealized 0.0%
ISHARES TR 0.2%
Value $445K Shares 3,958 Est. Cost Unrealized
ADVERUM BIOTECHNOLOGIES INC 0.0%
Value $47,000 Shares 15,000 Est. Cost $3.13 Unrealized